T0	Participants 0 7	Syncope
T1	Participants 94 101	syncope
T2	Participants 302 391	patients with syncope who are at intermediate risk for an adverse cardiovascular outcome.
T3	Participants 445 474	single-center study, patients
T4	Participants 759 851	One hundred three consecutive patients (53 women; mean age 64+/-17 years) entered the study.
T5	Participants 1637 1664	intermediate-risk patients.